Bharat Biotech has terminated the Memorandum of Understanding entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its Covid-19 vaccine Covaxin for the Brazilian market.

The termination of the MoU came after the deal with the Brazilian government for the supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.